1. Home
  2. SUNS vs NKTX Comparison

SUNS vs NKTX Comparison

Compare SUNS & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

HOLD

Current Price

$9.30

Market Cap

126.2M

Sector

Real Estate

ML Signal

HOLD

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.01

Market Cap

132.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUNS
NKTX
Founded
2023
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
126.2M
132.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
SUNS
NKTX
Price
$9.30
$2.01
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$13.00
$13.25
AVG Volume (30 Days)
99.5K
873.9K
Earning Date
03-05-2026
03-25-2026
Dividend Yield
12.90%
N/A
EPS Growth
1112.46
N/A
EPS
1.09
N/A
Revenue
$19,384,703.00
N/A
Revenue This Year
$165.88
N/A
Revenue Next Year
$46.38
N/A
P/E Ratio
$8.52
N/A
Revenue Growth
2540.16
N/A
52 Week Low
$7.80
$1.31
52 Week High
$12.35
$2.74

Technical Indicators

Market Signals
Indicator
SUNS
NKTX
Relative Strength Index (RSI) 44.49 42.66
Support Level $9.08 $1.91
Resistance Level $9.54 $2.27
Average True Range (ATR) 0.20 0.14
MACD 0.02 -0.05
Stochastic Oscillator 40.74 8.70

Price Performance

Historical Comparison
SUNS
NKTX

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: